In this article (Clin Cancer Res 2011;17:989–1000), which was published in the March 1, 2011, issue of Clinical Cancer Research (1), Fig. 4A was incorrectly labeled due to the following production error: The sequence for Day 1 and Day 7 was labeled “2h, 4h, 4h, 24h,” instead of “2h, 4h, 8h, 24h.” The corrected figure appears below. The online version has been corrected and no longer matches the print version.

1.
Gilmartin
AG
,
Bleam
MR
,
Groy
A
,
Moss
KG
,
Minthorn
EA
,
Kulkarni
SG
, et al
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition
.
Clin Cancer Res
2011
;
7
:
989
1000
.